Forge Life Science Partners Asset Manager Profile - aVenture Research
Forge Life Science Partners focuses on impactful investments in the life sciences sector, particularly in drug discovery and development. The firm typically participates in Series A and Series C funding rounds, partnering with innovative biotech entrepreneurs and operators to develop groundbreaking therapeutics.
Notable portfolio companies include Escient Pharmaceuticals, Idrx, and OnCusp Therapeutics, which have collectively raised significant capital. The team comprises seasoned biotech investors and entrepreneurs with extensive experience in the industry. Forge Life Science Partners offers unique value-add services, leveraging their deep expertise to support the growth and success of their portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.